{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Levittown",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82889",
      "recalling_firm": "Torrent Pharma Inc",
      "address_1": "2091 Hartel Ave",
      "address_2": "N/A",
      "postal_code": "19057-4506",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.",
      "recall_number": "D-1361-2019",
      "product_description": "Cetirizine HCL Oral Solution, USP 1mg/mL, 4 oz - BULK, PLD",
      "product_quantity": "361,260 bottles",
      "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).",
      "recall_initiation_date": "20190521",
      "center_classification_date": "20190613",
      "termination_date": "20201006",
      "report_date": "20190619",
      "code_info": "Lot #s: 17E015; 17E024; 17E044, Exp. 05/2019; 17F018, Exp. 06/2019; 17G012, Exp. 07/2019; 17K024, Exp. 10/2019; 17M004, Exp. 12/2019; 18B017, Exp. 02/2020; 18H023, Exp. 08/2020."
    }
  ]
}